Skip to main content


Center of Excellence

Leaders in the field sharing authoritative insights and institutional best practices.
Alice Egerton, PhD, discusses a study which found that symptom improvements in people with treatment-resistant schizophrenia who switch to clozapine may be related to reductions in glutamate in the caudate nucleus.
Christoph Correll, MD, and Sanjai Rao, MD, respond to questions asked by attendees of a Psych Congress 2020 session they presented on managing weight gain and metabolic disruptions in patients with schizophrenia.
Laura J. Fochtmann, MD, MBI, shares insights on a new set of evidence-based practice guidelines for the treatment of patients with schizophrenia, which she helped write.
In this video, Sanjai Rao, MD, of the University of California San Diego School of Medicine, discusses whether genomic data can aid in the diagnosis of schizophrenia.
In this video, psychiatrist Ilan Melnick, MD, discusses the transition of care of patients with serious mental illness such as schizophrenia, including the difficulties such patients face, how mental health clinicians can aid in the transition, and the benefits of using long-acting injectables.
In this video, Christoph U. Correll, MD, of Hofstra/Northwell in New York, discusses the possible clinical applications of the combination of olanzapine and the mu-opioid antagonist samidorphan.
In this video, Christoph U. Correll, MD, discusses additional research needed on the combination of olanzapine and the mu-opioid antagonist samidorphan.
Christoph U. Correll, MD, discusses the results of the ENLIGHTEN‑2 study, which compared weight gain and cardiometabolic side effects in patients taking olanzapine and patients taking olanzapine plus samidorphan.
Does seeing a patient via telepsychiatry complicate the Abnormal Involuntary Movement Scale (AIMS) exam? Find out from Psych Congress cochair Rakesh Jain, MD, MPH. 
Did you enjoy reading the Schizophrenia Center of Excellence Compendium? Let us know what you liked best and what you would like to see in future coverage.
Back to Top